Docoh
Loading...

JAGX Jaguar Health

News

From Benzinga Pro
Jaguar Health's Posts Crofelemer Data For Chemo-Induced Diarrhea In Breast Cancer Patients
19 Nov 21
Biotech, News, Penny Stocks, Health Care, Movers, Trading Ideas, General
Jaguar Health Inc (NASDAQ: JAGX)
Jaguar Health Announces Topline Results Of Investigator-Initiated Phase 2 Study Of Crofelemer
19 Nov 21
Biotech, General
Jaguar Health, Inc. (NASDAQ:JAGX) today announced topline results of the third-party, investigator-initiated Phase 2 HALT-D trial evaluating crofelemer for the prevention of chemotherapy-induced diarrhea (CID) in
Looking Into Jaguar Health's Return On Capital Employed
17 Nov 21
Earnings
According to data from Benzinga Pro, during Q3, Jaguar Health's (NASDAQ:JAGX) reported sales totaled $630.00 thousand. Despite a 17.71% increase in earnings, the company posted a loss of $9.53 million.
Jaguar Health: Q3 Earnings Insights
17 Nov 21
Earnings, News
Jaguar Health (NASDAQ:JAGX) reported its Q3 earnings results on Wednesday, November 17, 2021 at 08:00 AM. Here's what investors need to know about the announcement.
Jaguar Health Q3 EPS $(0.27) Misses $(0.17) Estimate, Sales $630.00K Miss $2.63M Estimate
17 Nov 21
Earnings, News
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.17) by 58.82 percent. This is a 57.14 percent increase over losses of $(0.63) per share from
Earnings Scheduled For November 17, 2021
17 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion.
Jaguar Health's Earnings Outlook
16 Nov 21
Earnings
Jaguar Health (NASDAQ:JAGX) is set to give its latest quarterly earnings report on Wednesday, 2021-11-17. Here's what investors need to know before the announcement. Analysts estimate that Jaguar Health will likely report an Earnings Per Share (EPS) of $-0.17
Earnings Scheduled For November 15, 2021
15 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.
Earnings Preview: Jaguar Health
12 Nov 21
Earnings
Jaguar Health (NASDAQ:JAGX) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts estimate that Jaguar Health will likely report an Earnings Per Share (EPS) of $-0.17
Jaguar Health Reports Completed Filing Of New Animal Drug Application For Conditional Approval Of Canalevia-CA1 To Treat Chemo-Induced Diarrhea In Dogs
2 Nov 21
Biotech, News, FDA, General
Canalevia™-CA1 is the first and only oral plant-based prescription drug candidate for CID in dogs Jaguar kicks off educational awareness contest in honor of International Jaguar Day; Click here to
Jaguar Health Shares See Light Volume Following Press Release Highlighting Closing Of Deal Between Its Italian Subsidiary, Napo EU And Dragon SPAC; BZ NOTE: The Italian Gov't. Cleared The Deal On Oct. 25
1 Nov 21
M&A
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the merger of its Italian subsidiary Napo EU S.p.A. and Dragon SPAC S.p.A. has closed. "We know shareholders and other stakeholders have been eagerly awaiting
64 Biggest Movers From Yesterday
28 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Wednesday's Intraday Session
27 Oct 21
Intraday Update, Markets, Movers
44 Stocks Moving In Wednesday's Mid-Day Session
27 Oct 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI) shares climbed 105.3% to $4.4350. AgriFORCE Growing Systems reported binding LOI to acquire a European agriculture/horticulture and agtech consulting firm for $29 million.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
27 Oct 21
Pre-Market Outlook, Markets, Movers
61 Biggest Movers From Yesterday
27 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the development 1,040 ART systems in Spain and Portugal.
Jaguar Health Shares Spike To Session High On Volume, Now Up ~19% For Session; Mention By Popular Benzinga Pro Community Member, Sandman, On Twitter
26 Oct 21
Movers, Trading Ideas
https://twitter.com/Sandman7591/status/1453036524044439556https://twitter.com/Sandman7591/status/1453036524044439556<
12 Health Care Stocks Moving In Monday's Intraday Session
25 Oct 21
Intraday Update, Markets, Movers
Jaguar Health Provides Updates on Crofelemer And Lechlemer Development Pipeline; Updates On Merger Of Napo E.U. S.p.A. And Dragon SPAC
7 Oct 21
News
Jaguar Health, Inc. (NASDAQ:JAGX) provided updates today regarding ongoing research and development related to the company's crofelemer drug product candidates, and also announced that Dragon SPAC S.p.A. and Napo EU
Jaguar Health Earnings Perspective: Return On Capital Employed
1 Oct 21
Earnings
Jaguar Health (NASDAQ:JAGX) brought in sales totaling $385.00 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 32.1%, resulting in a loss of $11.58 million.

Press releases

From Benzinga Pro
Jaguar Health Announces Topline Results of Investigator-Initiated Phase 2 Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients
19 Nov 21
News, Press Releases
Crofelemer is a novel, oral plant-based non-opioid antidiarrheal medicationSAN FRANCISCO, CA / ACCESSWIRE / November 19, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced topline results of the third-party,
Jaguar Health Reports 2021 Third Quarter Financial Results
17 Nov 21
Earnings, Press Releases
Mytesi® prescription volume increased 7.6% in Q3 2021 over Q2 2021Third quarter 2021 Mytesi net and gross sales were approximately $0.6 million and approximately $3.2 millionCompany expects to complete transition to
Jaguar Health's Italian Subsidiary Napo EU Appoints Massimo Mineo General Manager
16 Nov 21
News, Press Releases
REMINDER: Jaguar to host investor webcast Wednesday, November 17th at 8:30 a.m. Eastern regarding third quarter 2021 financials & business updates; Click here to register for webcastSAN FRANCISCO, CA / ACCESSWIRE /
Jaguar Health Investor Webcast Rescheduled for Wednesday, November 17th at 8:30 AM Eastern Time
15 Nov 21
News, Press Releases
Click here to register for webcastCompany plans to file Q3 2021 10-Q on November 17, 2021SAN FRANCISCO, CA / ACCESSWIRE / November 15, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company's investor
Jaguar Health to Host Investor Webcast Monday, November 15th at 8:30 AM Eastern Time Regarding Q3 2021 Financials & Business Updates
10 Nov 21
News, Press Releases
Click here to register for webcastCompany plans to file Q3 2021 10-Q on November 15, 2021SAN FRANCISCO, CA / ACCESSWIRE / November 10, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that company management will
Jaguar Health's Italian Subsidiary Napo EU Appoints Annabella Amatulli Chief Regulatory Officer
8 Nov 21
News, Press Releases
SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced the appointment by Napo EU S.p.A., the company's Italian subsidiary, of Annabella Amatulli as chief regulatory
Jaguar Health Completes Filing of New Animal Drug Application for Conditional Approval of Canalevia-CA1 (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs, Clearing Way for December 2021 Launch
2 Nov 21
News, Press Releases
Canalevia™-CA1 is the first and only oral plant-based prescription drug candidate for CID in dogsJaguar kicks off educational awareness contest in honor of International Jaguar Day; Click here to enterSAN
The Merger of Dragon SPAC S.p.A. and Napo EU S.p.A. has Closed
1 Nov 21
M&A, Press Releases
The combined entity is named Napo EU S.p.A.SAN FRANCISCO, CA / ACCESSWIRE / November 1, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the merger of its Italian subsidiary Napo EU S.p.A. and Dragon SPAC
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 Oct 21
News, Press Releases
SAN FRANCISCO, CA / ACCESSWIRE / October 29, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that, effective October 25, 2021, the Company granted nonstatutory
Italian Government Clears Merger Plan of Dragon SPAC S.p.A. and Jaguar Health's Italian Subsidiary Napo EU S.p.A. for Closing
25 Oct 21
News, Press Releases
Merger expected to be effective within a weekThe combined entity will be named Napo EU S.p.A.Merger effects the exclusive license agreement between Jaguar and Napo EU S.p.A. including up-front license fee due to
Jaguar Health Provides Updates on Crofelemer and Lechlemer Development Pipeline as well as Merger of Napo EU S.p.A. and Dragon SPAC S.p.A.
7 Oct 21
News, Press Releases
Dragon SPAC and Jaguar subsidiary Napo EU submit required notification to the Italian government in support of consummating the mergerResults accepted for third-party, investigator-initiated Phase 2 HALT-D study
Jaguar Health's Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award
30 Sep 21
News, Press Releases
Award celebrates Ms. Conte's 30-year, unrelenting commitment to supporting Indigenous communities in the Amazon and responsibly harvesting and commercializing the first-ever plant-based oral medicine approved under FDA
Jaguar Health Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Cancer Therapy-related Diarrhea on September 29, 2021
27 Sep 21
News, Press Releases
Leading oncologists discuss importance of supportive care for cancer patients to address debilitating diarrhea resulting from cancer therapyVirtual event 1:00 PM to 2:10 PM EasternRegistration open now for financial and
Jaguar Health Receives "Complete" Letter from FDA for Last of Four Major Technical Sections for the Company's Application for Conditional Approval of Canalevia (Crofelemer) for Chemotherapy-Induced Diarrhea (CID) in Dogs
23 Sep 21
News, Press Releases
Jaguar planning for launch of Canalevia™ for CID in dogs this DecemberCanalevia is the first and only oral plant-based prescription drug candidate for CID in dogsSAN FRANCISCO, CA / ACCESSWIRE / September 23, 2021
REMINDER: Jaguar Health to Host Investor Webcast Monday, September 20th at 8:30 AM Eastern Time
16 Sep 21
News, Press Releases
Click here to register for webcastJaguar kicks off educational awareness contest in honor of Indigenous Peoples' Day; Click here to enterSAN FRANCISCO, CA / ACCESSWIRE / September 16, 2021 / Jaguar Health, Inc.
Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
15 Sep 21
News, Press Releases
The conditional marketing authorization pathway in Europe for crofelemer for this orphan disease is the initial focus of Napo EU under the license agreement between Napo EU and Napo PharmaceuticalsJaguar to host investor
Jaguar Health Announces Closing of Private Placement Priced at a Premium to Market
14 Sep 21
Offerings, Press Releases
Participating investors include Jaguar CEO and CFO, Dragon SPAC S.p.A. sponsor Josh Mailman, and plant-based pharmaceutical manufacturing pioneer Indena S.p.A.Company to host investor webcast Monday, September 20th at
Jaguar Health Appoints Karen Brunke, Ph.D. as Corporate and Business Development EVP and Chip Whitlow as Animal Health Products Marketing Director
9 Sep 21
News, Press Releases
Appointments represent Jaguar's focus on forging business development partnerships to advance crofelemer development and access and preparing for the expected near-term approval and commercialization of crofelemer
Jaguar Health, Inc. Announces 1-for-3 Reverse Stock Split
3 Sep 21
News, Press Releases
Reverse split approved by majority of common stock shareholders at December 2020 special meeting of stockholdersShares of Jaguar common stock to begin trading on split-adjusted basis on September 8, 2021SAN FRANCISCO, CA
Jaguar Health Reports Voting Results from 2021 Annual Meeting of Stockholders
3 Sep 21
News, Press Releases
Proposals 1, 2, 4, 5 & 6 approvedSAN FRANCISCO, CA / ACCESSWIRE / September 3, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the